Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

BELLICUM PHARMACEUTICALS, INC (BLCM) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO"
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/10/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/05/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/05/2023 3 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 3 on BELLICUM PHARMACEUTICALS, INC
04/28/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/31/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G/A ARMISTICE CAPITAL, LLC reports a 10% stake in BELLICUM PHARMACEUTICALS, INC.
02/14/2023 SC 13G/A Ikarian Capital, LLC reports a 5.2% stake in BELLICUM PHARMACEUTICALS, INC.
01/20/2023 4/A Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 80,968 shares @ $0
01/05/2023 4 Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 60,414 shares @ $0
01/05/2023 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 74,739 shares @ $0
01/05/2023 4 Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 87,196 shares @ $0
01/05/2023 4 Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 121,452 shares @ $0
01/05/2023 4 Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 60,414 shares @ $0
01/04/2023 4/A Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 60,580 shares @ $0
12/12/2022 8-K Quarterly results
12/07/2022 8-K Quarterly results
11/18/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
11/10/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/24/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/24/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/14/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
09/02/2022 4 Klimovsky Judith V (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 35,082 shares @ $0
09/02/2022 4 DAVIS STEPHEN (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 43,400 shares @ $0
09/02/2022 4 Daly James M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 35,082 shares @ $0
09/02/2022 4 Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 46,489 shares @ $0
09/02/2022 4 Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 60,580 shares @ $0
09/01/2022 4/A Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Exercised 21,054 restricted stock units @ $0
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2022 4 Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC
Txns: Granted 400,000 options to buy @ $1.44, valued at $576k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy